SE7603070L - Ogiftig polymer samt sett for dess framstellning - Google Patents

Ogiftig polymer samt sett for dess framstellning

Info

Publication number
SE7603070L
SE7603070L SE7603070A SE7603070A SE7603070L SE 7603070 L SE7603070 L SE 7603070L SE 7603070 A SE7603070 A SE 7603070A SE 7603070 A SE7603070 A SE 7603070A SE 7603070 L SE7603070 L SE 7603070L
Authority
SE
Sweden
Prior art keywords
preparation
toxic polymer
toxic
polymer
Prior art date
Application number
SE7603070A
Other languages
English (en)
Other versions
SE431550B (sv
Inventor
Paolo Ferruti
Rodolfo Paoletti
L Puglisi
Original Assignee
Paolo Ferruti
Rodolfo Paoletti
L Puglisi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paolo Ferruti, Rodolfo Paoletti, L Puglisi filed Critical Paolo Ferruti
Publication of SE7603070L publication Critical patent/SE7603070L/sv
Publication of SE431550B publication Critical patent/SE431550B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/02—Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pyridine Compounds (AREA)
SE7603070A 1974-10-15 1976-03-08 Forfarande for framstellning av en ogiftig polymer omfattande nikotinsyraradikaler bundna till sterkelse SE431550B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT28420/74A IT1044798B (it) 1974-10-15 1974-10-15 Alti polimeri contenenti acido nicotinico processo per la loro preparazione e loro impiego

Publications (2)

Publication Number Publication Date
SE7603070L true SE7603070L (sv) 1977-09-09
SE431550B SE431550B (sv) 1984-02-13

Family

ID=11223568

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7603070A SE431550B (sv) 1974-10-15 1976-03-08 Forfarande for framstellning av en ogiftig polymer omfattande nikotinsyraradikaler bundna till sterkelse

Country Status (7)

Country Link
US (1) US4067876A (sv)
JP (1) JPS52114688A (sv)
DE (1) DE2546242A1 (sv)
FR (1) FR2346016A1 (sv)
GB (3) GB1526720A (sv)
IT (1) IT1044798B (sv)
SE (1) SE431550B (sv)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166902A (en) * 1974-10-14 1979-09-04 Paolo Ferruti High polymers containing nicotinic acid, process for their preparation and their use
US4169923A (en) * 1974-10-15 1979-10-02 Paolo Ferruti High polymers containing nicotinic acid, process for their preparation and their use
US4515658A (en) * 1984-08-20 1985-05-07 Nalco Chemical Company Retention aids
US5310786A (en) * 1987-01-08 1994-05-10 Hoechst Aktiengesellschaft Reversibly precipitable, water-soluble polymer conjugates
DE3700308A1 (de) * 1987-01-08 1988-07-21 Hoechst Ag Reversibel ausfaellbare, wasserloesliche polymerkonjugate, ihre herstellung und verwendung in der homogenen katalyse
US20060263428A1 (en) * 1993-09-20 2006-11-23 Eugenio Cefali Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6080428A (en) * 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6129930A (en) * 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6676967B1 (en) * 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US20080045573A1 (en) * 1993-09-20 2008-02-21 Bova David J Methods and Sustained Release Nicotinic Acid Compositions for Treating Hyperlipidemia
ZA978537B (en) 1996-09-23 1998-05-12 Focal Inc Polymerizable biodegradable polymers including carbonate or dioxanone linkages.
DE69833487T9 (de) 1997-06-12 2007-03-01 Innovata Plc, Ruddington Polymer-wirkstoff-konjugate zur behandlung von krebs
US7736636B2 (en) * 2003-02-12 2010-06-15 Shaker Mousa Method for treating occlusive vascular diseases & wound healing
US20150034098A1 (en) 2013-07-11 2015-02-05 Aqua Turf International, Inc. Air filtration mask with opening front cover

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2701244A (en) * 1953-06-12 1955-02-01 Chemstrand Corp Method for rendering acrylonitrile polymers dye-receptive

Also Published As

Publication number Publication date
SE431550B (sv) 1984-02-13
GB1527351A (en) 1978-10-04
FR2346016A1 (fr) 1977-10-28
JPS5324471B2 (sv) 1978-07-20
GB1526795A (en) 1978-09-27
IT1044798B (it) 1980-04-21
GB1526720A (en) 1978-09-27
US4067876A (en) 1978-01-10
FR2346016B1 (sv) 1979-10-05
DE2546242A1 (de) 1976-04-29
JPS52114688A (en) 1977-09-26

Similar Documents

Publication Publication Date Title
AT347888B (de) Windelverschluss
AT347889B (de) Windelverschluss
SE7505638L (sv) Engangsbloja med endflikorgan samt settt for dess framstellning.
AT352043B (de) Windeleinlage
JPS54109425A (en) Light sensitive element
SE412652B (sv) Avsokningsanordning med planfeltsegenskaper
SE396141B (sv) Anordning for hastighetsavkenning samt forfarande for dess framstellning
DK300675A (da) Tverbindingsholdig copolymer
FR2294629A1 (fr) Dispositif de recolte
AT347374B (de) Windelverschluss
SE7510084L (sv) Strengpressat plastnet
SE7603070L (sv) Ogiftig polymer samt sett for dess framstellning
AT347375B (de) Windelverschluss
BR7507820A (pt) Composicao vulcanizavel
BE831449A (nl) Ontsnappingsinrichting
AT352045B (de) Windelverschluss
AT347377B (de) Windelverschluss
BE835352A (fr) Fermeture de fut
BR7503437A (pt) Dispositivo de icamento
IT1042724B (it) Copolimeri acrilonitrolici termoplastici
SE395724B (sv) Blixtlas samt forfarande for dess framstellning
AT347376B (de) Windelverschluss
SE405746B (sv) Valvelement samt forfarande for dess tillverkning
SE396314B (sv) Imiterad jalusi samt forfaringssett for dess framstellning
JPS5117578A (ja) Koatsushadanki